Skip to content
MMJ Gazette
  Tuesday 26 August 2025
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
August 23, 2025South Dakota Marijuana Industry Rallies Behind Crackdown on Hemp THC August 22, 2025Florida Court Says Medical Marijuana Patients Can Own Guns August 7, 2025Los Angeles Greenlighted Massive Fee Hikes for Cannabis Operators—And Businesses Say It Could Break Them August 6, 2025Ayr Wellness to Shutter Grow Sites in Massachusetts and Nevada Amid Financial Strain August 4, 2025Cannabis Businesses Face Tightrope Act as Rules Shift State to State August 3, 2025Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves August 2, 2025Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E August 2, 2025Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn July 31, 2025Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off July 30, 2025Oklahoma’s Marijuana Legalisation Fight Is Back—And It’s Getting Personal
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  Marijuana  New York Cannabis Recall Sparks Fresh Scrutiny Over Pesticide Testing
MarijuanaNews

New York Cannabis Recall Sparks Fresh Scrutiny Over Pesticide Testing

Lars BeckersLars Beckers—July 18, 20250
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

New York state cannabis regulators have pulled several marijuana products from shelves this week after pesticide contamination was found in products that had already been cleared for sale. The move throws the state’s cannabis testing system under fresh scrutiny — again.

It’s the second recall in less than a month. This time, the issue stems from East End Flower Farm’s “Harvest” brand, which was tested by a lab that’s since lost its testing privileges. No illnesses have been reported so far, but the reputational fallout is already spreading.

A Second Recall in Weeks Is Raising Eyebrows

The Office of Cannabis Management (OCM) announced the recall on July 14, flagging three product lots from East End Flower Farm. The issue? Pesticide residue above legal limits — at least in one batch that was retested. The other two batches weren’t retested at all, but regulators didn’t want to take any chances.

This isn’t just about one farm. This is about trust. When the first recall hit in late June, it caught the attention of growers, dispensaries and consumers. But now a second recall so soon has people asking bigger questions.

And here’s the kicker — both recalls are linked to the same now-discredited testing lab: Lexachrom Analytical Laboratory.

The Lab at the Centre of the Storm

Lexachrom Analytical had been an approved lab, conducting the safety and compliance tests required before cannabis products hit dispensary shelves. But now, its name has been scrubbed from the OCM’s approved list.

The lab is no longer authorised to test marijuana in New York, and the OCM hasn’t minced words about why. In a quiet but firm update to its site, the agency made clear that Lexachrom’s test results could not be relied upon.

That’s a big deal. Because:

  • Cannabis testing in New York is the last line of defence before a product goes to the public.

  • Faulty tests could mean pesticides, mould, or heavy metals end up in the supply chain unnoticed.

  • Once confidence in labs erodes, so does the integrity of the whole regulatory system.

The OCM didn’t say whether Lexachrom’s failures were due to poor procedures, faulty equipment, or something worse. But either way, the damage has been done.

East End Flower Farm Under Pressure

East End Flower Farm, based on Long Island, voluntarily retested one of the three lots. The results came back over the allowable pesticide limit — not a good look. The other two lots weren’t retested, but that didn’t stop the OCM from yanking them too.

It’s not clear why only one lot was retested. Cost? Time? Or perhaps they didn’t want to risk a second fail.

The farm hasn’t responded publicly yet. But industry insiders say this kind of contamination could be devastating for small producers who rely on brand trust and quality to stay afloat in a crowded market.

There was no sign of illness, thankfully. But the reputational hit is already sinking in.

Growing Pains for New York’s Legal Market

New York’s adult-use marijuana market is still in its toddler phase. Legal sales only began in December 2022, and since then, the rollout has been marred by delays, lawsuits, supply issues, and now — lab problems.

Testing labs are supposed to be the most scientific, buttoned-up part of the whole operation. When that breaks down, it makes everything else feel shaky.

Let’s be real: consumers buying cannabis legally expect safety. That’s part of the whole point of regulation. They’re not looking for wild west weed — they want peace of mind.

And with competition from illegal sellers still rampant across New York City and beyond, every scandal like this gives the black market a tiny win.

What Happens Next?

The OCM says it’s reviewing lab protocols, but hasn’t announced any major changes yet. Insiders expect tighter scrutiny going forward — possibly even federal-style inspections.

In the meantime, dispensaries have been told to pull the affected products. Retailers are expected to comply quickly, especially given the reputational stakes.

Here’s a look at the recalled products:

Brand Lot Number Issue Identified Action Taken
Harvest 010124-01 Pesticides above limit Recalled
Harvest 010124-02 Not retested Recalled
Harvest 010124-03 Not retested Recalled

One batch failed. Two more weren’t checked again, but were still pulled as a precaution.

That’s how shaky things are right now.

Trust Issues Could Linger

Consumer trust takes a while to build — and only one bad headline to dent. It’s too early to tell if these recalls will have a lasting impact on public perception, but there’s definitely chatter.

Some dispensaries are taking extra steps, double-checking products even after they pass lab testing. Others are pressing state officials to improve oversight on labs themselves, not just growers.

For now, the OCM is walking a tightrope: act fast, stay transparent, and try to fix the pipeline without stalling it. No easy task.

And the industry? It’s watching every move.

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

Omaha Tribe Breaks Ranks with Nebraska, Legalises Marijuana for Adult Use
Congress Budget Bills Signal Split on Marijuana Policy, But Medical Use Still Safe
Related posts
  • Related posts
  • More from author
Marijuana

South Dakota Marijuana Industry Rallies Behind Crackdown on Hemp THC

August 23, 20250
Marijuana

Florida Court Says Medical Marijuana Patients Can Own Guns

August 22, 20250
Cannabis

Los Angeles Greenlighted Massive Fee Hikes for Cannabis Operators—And Businesses Say It Could Break Them

August 7, 20250
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • South Dakota Marijuana Industry Rallies Behind Crackdown on Hemp THC
  • Florida Court Says Medical Marijuana Patients Can Own Guns
  • Los Angeles Greenlighted Massive Fee Hikes for Cannabis Operators—And Businesses Say It Could Break Them
  • Ayr Wellness to Shutter Grow Sites in Massachusetts and Nevada Amid Financial Strain
  • Cannabis Businesses Face Tightrope Act as Rules Shift State to State
  • Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves
  • Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E
  • Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn
  • Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off
  • Oklahoma’s Marijuana Legalisation Fight Is Back—And It’s Getting Personal
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors